These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7257361)
21. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121 [TBL] [Abstract][Full Text] [Related]
22. Is it a cosmetic, a drug, or both? (Or is it soap?). Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587 [No Abstract] [Full Text] [Related]
23. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications. Torres A Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737 [TBL] [Abstract][Full Text] [Related]
25. FDA proposes that patient package insert program be rescinded. Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117 [No Abstract] [Full Text] [Related]
26. The history of patient package inserts in the United States. Moore SR; Morris LA; Groft SC Can Pharm J; 1981 May; 114(5):173-5. PubMed ID: 10251273 [No Abstract] [Full Text] [Related]
27. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285 [TBL] [Abstract][Full Text] [Related]
28. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
29. Patient package inserts--a good idea gone bad. Kough RH Pa Med; 1978 Jul; 81(7):15-6. PubMed ID: 662407 [No Abstract] [Full Text] [Related]
30. Patient package inserts-an industry viewpoint. Waife SO Trans Stud Coll Physicians Phila; 1977 Jul; 45(1):4-7. PubMed ID: 617242 [No Abstract] [Full Text] [Related]
31. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule. Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154 [TBL] [Abstract][Full Text] [Related]
33. Hand in hand: unit-of-use packages and patient package inserts. Archambault GF Hosp Formul; 1976 Jun; 11(6):336. PubMed ID: 10236470 [No Abstract] [Full Text] [Related]
34. Patient package inserts: the patient's right to know. Kruger ID Bull Am Coll Physicians; 1977 Jan; 18(1):18-9. PubMed ID: 10235933 [No Abstract] [Full Text] [Related]
35. Patient package inserts--instructions or intrusions? Harvey MW Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481 [No Abstract] [Full Text] [Related]
36. Some issues related to patient package inserts. Fink JL Hosp Formul; 1979 Feb; 14(2):181-3. PubMed ID: 10240143 [No Abstract] [Full Text] [Related]
37. Improved access to drug safety information from the Food and Drug Administration. Baer RK S D Med; 2007 Nov; 60(11):448-9. PubMed ID: 18196689 [No Abstract] [Full Text] [Related]
38. Dr. Tice on patient package inserts. Tice LF Am Pharm; 1978 Jan; 18(1):29. PubMed ID: 622926 [No Abstract] [Full Text] [Related]
39. Regents voice policy on two issues. 2. Patient package inserts. Bull Am Coll Physicians; 1977 Jun; 18(6):9. PubMed ID: 10304643 [No Abstract] [Full Text] [Related]
40. The FDA's enforcement of IRBs and patient informed consent. Kelsey FO Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]